Inovio Pharmaceuticals, Inc.
PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy

Last updated:

Abstract:

Disclosed herein is a vaccine comprising an antigen and PD1 antibody and/or PDL1 antibody. Also disclosed herein is a method for enhancing an immune response in a subject. The method may comprise administering the vaccine to the subject in need thereof.

Status:
Grant
Type:

Utility

Filling date:

6 Jan 2015

Issue date:

17 Nov 2020